{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:57:40Z","timestamp":1783105060929,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2010-15547"],"award-info":[{"award-number":["SAF2010-15547"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017266","name":"Gobierno de Navarra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","award":["63\/09"],"award-info":[{"award-number":["63\/09"]}],"id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004435","name":"Universidad de Navarra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004435","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["TD1004"],"award-info":[{"award-number":["TD1004"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006671","name":"Fundaci\u00f3n Caja Navarra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejpb.2022.04.007","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T12:03:21Z","timestamp":1650542601000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["In vivo biodistribution of edelfosine-loaded lipid nanoparticles radiolabeled with Technetium-99\u00a0m: Comparison of administration routes in mice"],"prefix":"10.1016","volume":"175","author":[{"given":"Beatriz","family":"Lasa-Sarac\u00edbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souhaila H.","family":"El Moukhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Tsotakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Xanthopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Loudos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Bouziotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Blanco-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2022.04.007_b0005","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.crhy.2011.06.001","article-title":"Nanomedicine, nanotechnology in medicine","volume":"12","author":"Boisseau","year":"2011","journal-title":"Comptes Rendus Phys."},{"issue":"10","key":"10.1016\/j.ejpb.2022.04.007_b0010","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1517\/17425247.2012.717928","article-title":"Lipid nanoparticles for cancer therapy: state of the art and future prospects","volume":"9","author":"Lasa-Saracibar","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ejpb.2022.04.007_b0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: Progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer."},{"key":"10.1016\/j.ejpb.2022.04.007_b0020","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10246","article-title":"Nanoparticles in the clinic: An update post COVID-19 vaccines","volume":"6","author":"Anselmo","year":"2021","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ejpb.2022.04.007_b0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery \u2013 a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2022.04.007_b0030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.addr.2021.03.004","article-title":"Oral lipid nanomedicines: Current status and future perspectives in cancer treatment","volume":"173","author":"El Moukhtari","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.ejpb.2022.04.007_b0035","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2217\/nnm.11.134","article-title":"Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles","volume":"7","author":"Estella-Hermoso de Mendoza","year":"2012","journal-title":"Nanomedicine."},{"issue":"3","key":"10.1016\/j.ejpb.2022.04.007_b0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2011.07.030","article-title":"In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma","volume":"156","author":"Estella-Hermoso de Mendoza","year":"2011","journal-title":"J. Control. Release."},{"issue":"2","key":"10.1016\/j.ejpb.2022.04.007_b0045","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ijpharm.2013.04.068","article-title":"Efficacy of edelfosine lipid nanoparticles in breast cancer cells","volume":"454","author":"Aznar","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2022.04.007_b0050","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.canlet.2013.01.018","article-title":"Edelfosine lipid nanosystems overcome drug resistance in leukemic cell lines","volume":"334","author":"Lasa-Sarac\u00edbar","year":"2013","journal-title":"Cancer Lett."},{"issue":"26","key":"10.1016\/j.ejpb.2022.04.007_b0055","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/onc.2010.131","article-title":"Lipid raft-targeted therapy in multiple myeloma","volume":"29","author":"Mollinedo","year":"2010","journal-title":"Oncogene."},{"issue":"7","key":"10.1016\/j.ejpb.2022.04.007_b0060","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1158\/1078-0432.CCR-09-2456","article-title":"In vitro and In vivo Selective Antitumor Activity of Edelfosine against Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Involving Lipid Rafts","volume":"16","author":"Mollinedo","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejpb.2022.04.007_b0065","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.2147\/IJN.S262395","article-title":"Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats","volume":"15","author":"Zakarial Ansar","year":"2020","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.ejpb.2022.04.007_b0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/cmmi.1530","article-title":"Radiolabeling approaches of nanoparticles with 99mTc","volume":"8","author":"Psimadas","year":"2013","journal-title":"Contrast Media Mol. Imaging."},{"key":"10.1016\/j.ejpb.2022.04.007_b0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijpharm.2014.01.042","article-title":"Comparative in vitro stability and scintigraphic imaging for trafficking and tumor targeting of a directly and a novel 99mTc(I)(CO)3 labeled liposome","volume":"465","author":"Fragogeorgi","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.04.007_b0080","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fchem.2018.00224","article-title":"A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT\/MR Imaging of Angiogenesis","volume":"6","author":"Tsoukalas","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejpb.2022.04.007_b0085","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1166\/jbn.2012.1412","article-title":"Preliminary evaluation of a 99mTc labeled hybrid nanoparticle bearing a cobalt ferrite core: In vivo biodistribution","volume":"8","author":"Psimadas","year":"2012","journal-title":"J. Biomed. Nanotechnol."},{"issue":"6","key":"10.1016\/j.ejpb.2022.04.007_b0090","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1166\/jnn.2015.9620","article-title":"Two novel nanosized radiolabeled analogues of somatostatin for neuroendocrine tumor imaging","volume":"15","author":"Orocio-Rodr\u00edguez","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ejpb.2022.04.007_b0095","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.2147\/IJN.S157426","article-title":"Shafiee Ardestani, Technetium-99m chelator-free radiolabeling of specific glutamine tumor imaging nanoprobe: in vitro and in vivo evaluations","volume":"13","author":"Ghoreishi","year":"2018","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.ejpb.2022.04.007_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103572","article-title":"Synthesis and characterization of novel 99mTc-DGC nano-complexes for improvement of heart diagnostic","volume":"96","author":"Ardestani","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejpb.2022.04.007_b0105","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1016\/j.jchromb.2009.10.020","article-title":"Comparative study of A HPLC\u2013MS assay versus an UHPLC\u2013MS\/MS for anti-tumoral alkyl lysophospholipid edelfosine determination in both biological samples and in lipid nanoparticulate systems","volume":"877","author":"Estella-Hermoso de Mendoza","year":"2009","journal-title":"J. Chromatogr. B."},{"issue":"5","key":"10.1016\/j.ejpb.2022.04.007_b0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/10717540802006500","article-title":"Etoposide Loaded PLGA and PCL Nanoparticles II: Biodistribution and Pharmacokinetics after Radiolabeling with Tc-99m","volume":"15","author":"Snehalatha","year":"2008","journal-title":"Drug Deliv."},{"issue":"5","key":"10.1016\/j.ejpb.2022.04.007_b0115","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1039\/D0CS00384K","article-title":"Radiolabelling of nanomaterials for medical imaging and therapy","volume":"50","author":"Pellico","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"7","key":"10.1016\/j.ejpb.2022.04.007_b0120","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1021\/mp300701e","article-title":"Augmented Anticancer Activity of a Targeted, Intracellularly Activatable, Theranostic Nanomedicine Based on Fluorescent and Radiolabeled, Methotrexate-Folic Acid-Multiwalled Carbon Nanotube Conjugate","volume":"10","author":"Das","year":"2013","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2022.04.007_b0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2005.02.028","article-title":"Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton\u2019s lymphoma tumor bearing mice","volume":"105","author":"Harivardhan Reddy","year":"2005","journal-title":"J. Control. Release."},{"issue":"6","key":"10.1016\/j.ejpb.2022.04.007_b0130","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4155\/tde.13.37","article-title":"Intracellular delivery of polymeric nanocarriers: a matter of size, shape, charge, elasticity and surface composition","volume":"4","author":"Agarwal","year":"2013","journal-title":"Ther. Deliv."},{"issue":"2","key":"10.1016\/j.ejpb.2022.04.007_b0135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2012.12.021","article-title":"Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier","volume":"166","author":"Beloqui","year":"2013","journal-title":"J. Control. Release."},{"issue":"3","key":"10.1016\/j.ejpb.2022.04.007_b0140","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1158\/1078-0432.CCR-08-1654","article-title":"Antitumor Alkyl Ether Lipid Edelfosine: Tissue Distribution and Pharmacokinetic Behavior in Healthy and Tumor-Bearing Immunosuppressed Mice","volume":"15","author":"de Mendoza","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"1-2","key":"10.1016\/j.ejpb.2022.04.007_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2014.07.053","article-title":"Lipid nanoparticles protect from edelfosine toxicity in vivo","volume":"474","author":"Lasa-Sarac\u00edbar","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.04.007_b0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11095-019-2745-x","article-title":"Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies?","volume":"37","author":"Al Shoyaib","year":"2019","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122000790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122000790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:41:56Z","timestamp":1777592516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641122000790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":30,"alternative-id":["S0939641122000790"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.04.007","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo biodistribution of edelfosine-loaded lipid nanoparticles radiolabeled with Technetium-99\u00a0m: Comparison of administration routes in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}